期刊文献+

壳聚糖作为缓释重组人骨形态发生蛋白-2载体的实验研究 被引量:2

In Vitro Experimental Study on Chitosan as Carrier for Sustained Release of Recombinant Human Bone Morphogenetic Protein-2
下载PDF
导出
摘要 目的:将壳聚糖作为重组人骨形态发生蛋白2(rhBMP2)的载体,通过体外释放实验观测rhBMP2在壳聚糖中释放的动力学过程,探讨壳聚糖对rhBMP2的缓释作用。方法:采用乳液冷冻干燥法制作rhBMP2/壳聚糖支架,单纯壳聚糖支架为对照组。对材料进行扫描电镜观察;将支架材料在磷酸盐缓冲液(PBS)中持续浸泡,通过高效液相色谱分析仪检测不同时间点浸出液中rhBMP2的含量,进行累积释放量的动态观察,绘制rhBMP2释放曲线。结果:支架材料的形态学观察呈疏松多孔海绵状;rhBMP2从支架材料中释放的动力学过程第1天表现为“爆发性”释放(33.2%);第27天rhBMP2出现快速释放;第814天释放速度减慢;第1530天出现缓慢而持久的释放,至1个月释放量达81.3%。结论:多孔壳聚糖支架对rhBMP2有缓慢而持久的体外释放作用,可作为rhBMP2的缓释载体,为rhBMP2持续发挥骨诱导作用提供初步的实验基础。 Objective: To assess the feasibility of chitosan scaffold as the carrier for controlled release of recombinant human bone morphogenetic protein-2(rhBMP-2) and evaluate the release kinetics of rhBMP-2 through in vitro release test. Methods: The chitosan scaffolds with rhBMP-2 sustained release system were made by emulsion freeze-dried method, and were compared with the empty chitosan scaffolds as control group. The samples were observed with scanning electron microscope. The samples were immerged into phosphate buffer solution(PBS). The released rhBMP-2 content from the samples was dynamically observed using high performance liquid chromatography at various set times. The curve of cumulative rhBMP-2 release kinetics was designed. Results: The surface and section of the scaffold was loose, multipore and sponginess. An initial burst release (33.2%) of the incorporated rhBMP-2 was observed during the first day; rhBMP-2 had been released rapidly during the 2nd to 7th day; released slowly during the 8th to 14th day;followed by a sustained release for the 15th to 30th day, which reached 81.3% at the 30th day. Conclusion: It can be concluded that the loose chitosan showed its characteristics as a sustained delivery system for rhBMP-2 and may be used as a sustained release carrier for rhBMP-2. It provided initial elements for rhBMP-2 continually inducing bone formation in bone tissue engineering.
出处 《武汉大学学报(医学版)》 CAS 2006年第2期210-213,共4页 Medical Journal of Wuhan University
关键词 壳聚糖 骨形态发生蛋白 缓释 载体 Chitosan Bone Morphogenetic Protein Sustained Release Scaffold
  • 相关文献

参考文献5

二级参考文献17

  • 1[1]Winn SR, Uludag H, Hollinger JO. Carrier system for Bone Morphogenetics Proteins [J]. Clin Orthop, 1999, 367: 95 ~106.
  • 2[2]Fernandez E, Ginebra MP, Boltong MG, et al, Kinetic study of the setting reaction of a calcium phosphate bone cement [J]. J Biomed Mater Res, 1996, 32(3) :367~74.
  • 3[3]Otsuka M, Matsuda Y, Suwa Y, et al, A novel skeletal drug delivery system using self - setting calcium phosphate cement 2: Physicochemical properties and drug release rate of the cement- containing indomethecin [J]. J Pharm Sci, 1994, 83(5):611~5.
  • 4[4]Otsuka M, Matsuda Y, Suwa Y, et al, A novel skeletal drug delivery system using self - setting calcium phosphate cement 3: Physicochemical properties and drug release rate of bovine insulin and bovine albumin[J]. J Pharm Sci, 1994, 83(2):255~8.
  • 5[5]Otsuka M, Matsuda Y, Suwa Y, et al, A novel skeletal drug delivery system using self- setting calcium phosphate cement 4:Effects of the mixing solution volume on the drug release rate of heterogeneous aspirin - loaded cement [J]. J Pharm Sci, 1994, 83(2) :259~63.
  • 6Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science, 1988, 242:1528-1534.
  • 7Whang K, Thomas CK, Nuber G, et al. A novel method to fabricate bioabsorbable scaffolds. Polymer, 1995, 36:837-842.
  • 8Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 1997,28:5-24.
  • 9Winn SR, Uludag H, Hollinger JO. Carrier systems for bone morphogenetic proteins. Clin Orthop, 1999, (367 Suppl):95-106.
  • 10Whang K, Goldstick TK, Healy KE. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials, 2000, 21:2545-2551.

共引文献26

同被引文献41

  • 1孟志斌,李德豪,周健强,纪志华,王挺瑞,黎坚,付昆,李俊,李洪潮,张英.可吸收珊瑚羟基磷灰石与天然珊瑚修复骨缺损的组织学及影像学分析[J].生物骨科材料与临床研究,2007,4(5):10-15. 被引量:9
  • 2Rocchietta I, Fontana F, Simion M. Clinical outcomes of vertical bone augmentation to enable dental implant placement: a systematic review[ J]. J Clin Periodontol, 2008,35 (8 Suppl) :203-215.
  • 3Ono D, Jimbo R, Kawachi G, et al. Lateral bone augmentation with newly developed beta-tricalcium phosphate block: an experimental study in the rabbit mandible[ J]. Clin Oral Implants Res, 2011,22 (12) : 1366-1371.
  • 4Koeter S, Tigchelaar SJ, Farla P, et al. Coralline hydroxyapatite is a suitable bone graft substitute in an intra-articular goat defect model [ J]. J Biomed Mater Res B Appl Biomater, 2009,90( 1 ) : 116-122.
  • 5Ning Y, Wei T, Defu C, et al. The research of degradability of a no- vel biodegradable eoralline hydroxyapatite after implanted into rabbit [J]. J Biomed Mater Res A, 2009,88(3) :741-746.
  • 6Kubo T, Doi K, Hayashi K, et al. Comparative evaluation of bone regeneration using spherical and irregularly shaped granules of inter- connected porous hydroxylapatite. A beagle dog study [ J]. J Prosth- odont Res, 2011,55(2) :104-109.
  • 7Thalgott JS, Klezl Z, Timlin M, et al. Anterior lumbar interbody fusion with processed sea coral (coralline hydroxyapatite) as part of a circumferential fusion [ J ]. Spine, 2002,27 ( 24 ) : 518-527.
  • 8Tian W, Wang Y, Liu B. The clinical research of coralline hydroxyapatite used in cervical surgery[ J]. Chin Surg J, 2000,11 (3) :827-830.
  • 9Reed A, Steven J, Cbrista R, et al. Long-term bone ingrowth and residual microhardness of porous block hydroxyapatite implants in humans[J]. J Oral Maxil Surg, 1998,5(6) :297-301.
  • 10Lu J, Descamps M, Dejou J, et al. The biodegradation mechanism of calcium phosphate biomaterials in bone [ J ]. J Biomed Mater Res, 2002,63 (4) :408-412.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部